Candida Auris: Hospitals mobilize to fight the deadly infection (Video). More Videos Below.
https://youtu.be/hnqFdKSG6-A
Auris all over the room, even on the ceiling?.
Mustang (MBIO) Balance Sheet Bolstered With $83 Million in Cash.
Mustang Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
NEW YORK, Aug. 09, 2019 (GLOBE...
Adding Sorrento Therapeutics (SRNE) to CoronaVirus Watch List.
LIVE QUOTE
Of course, we need not have to say, this is not an idea for widows...
Tempest Therapeutics’ (TPST) Stock Jumps 1,980%. $0.25 to $5.20
Yes, Good Things Can Happen in Phase I Folks!
OMG, That's $25,000 to $520,000. Party time. And yes Irene,...
Hapbee Closes $6.5 Million Private Placement and Provides Corporate Update.
VANCOUVER, BC, July 17, 2020 /PRNewswire/ - Hapbee Technologies, Inc. ("Hapbee" or the "Company"), a wellness technology company developing the revolutionary Hapbee wearable, is pleased to announce...
He Shoots And He Scores. Ardelyx (ARDX) Gains 78%. Happy New Year!
Ah yes, and Gains Come to the Patient, as the FDA Moves the Ardelyx Ball Further Along.
Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.
Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant
PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...
AR Threats Report (CDC)
This report is dedicated to the 48,700 familieswho lose a loved one each year to antibiotic resistanceor Clostridioides difficile, and the...
Up 2,950% is Novavax (NVAX) Still a Buy?
Up 4,002% at it's peak from where we added it to the Corona Stock Review Watch List at 7.80, Thomas Niel from...
Oramed (ORMP) $5.24, Focused on Pill Form Insulin. Is China First?
New technology could revolutionize market of 500 million diabetes patients (i24 News).
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
